Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
- PMID: 31157760
- DOI: 10.3791/59370
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
Abstract
Extracorporeal photochemotherapy (ECP) is a widely used cancer immunotherapy for cutaneous T cell lymphoma (CTCL), operative in over 350 university centers worldwide. While ECP's clinical efficacy and exemplary safety profile have driven its widespread use, elucidation of the underlying mechanisms has remained a challenge, partly owing to lack of a laboratory ECP model. To overcome this obstacle and create a simple, user-friendly platform for ECP research, we developed a scaled-down version of the clinical ECP leukocyte-processing device, suitable for work with both mouse models, and small human blood samples. This device is termed the Transimmunization (TI) chamber, or plate. In a series of landmark experiments, the miniaturized device was used to produce a cellular vaccine that regularly initiated therapeutic anti-cancer immunity in several syngeneic mouse tumor models. By removing individual factors from the experimental system and ascertaining their contribution to the in vivo anti-tumor response, we then elucidated key mechanistic drivers of ECP immunizing potential. Collectively, our results revealed that anti-tumor effects of ECP are initiated by dendritic cells (DC), physiologically generated through blood monocyte interaction with platelets in the TI plate, and loaded with antigens from tumor cells whose apoptotic cell death is finely titrated by exposure to the photoactivatable DNA cross-linking agent 8-methoxypsoralen and UVA light (8-MOPA). When returned to the mouse, this cellular vaccine leads to specific and transferable anti-tumor T cell immunity. We verified that the TI chamber is also suitable for human blood processing, producing human DCs fully comparable in activation state and profile to those derived from the clinical ECP chamber. The protocols presented here are intended for ECP studies in mouse and man, controlled generation of apoptotic tumor cells with 8-MOPA, and rapid production of physiologic human and mouse monocyte-derived DCs for a variety of applications.
Similar articles
-
Extracorporeal Photochemotherapy Drives Monocyte-to-Dendritic Cell Maturation to Induce Anticancer Immunity.Cancer Res. 2018 Jul 15;78(14):4045-4058. doi: 10.1158/0008-5472.CAN-18-0171. Epub 2018 May 15. Cancer Res. 2018. PMID: 29764863
-
Rapid Production of Physiologic Dendritic Cells (phDC) for Immunotherapy.Methods Mol Biol. 2020;2097:173-195. doi: 10.1007/978-1-0716-0203-4_11. Methods Mol Biol. 2020. PMID: 31776926
-
Induction of anti-tumor CD8 T cell responses by experimental ECP-induced human dendritic antigen presenting cells.Transfus Apher Sci. 2016 Aug;55(1):146-52. doi: 10.1016/j.transci.2016.06.001. Epub 2016 Jun 6. Transfus Apher Sci. 2016. PMID: 27317354
-
Efficient tumor antigen loading of dendritic antigen presenting cells by transimmunization.Technol Cancer Res Treat. 2002 Feb;1(1):65-9. doi: 10.1177/153303460200100109. Technol Cancer Res Treat. 2002. PMID: 12614179 Review.
-
Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphomas.Ann N Y Acad Sci. 2001 Sep;941:123-38. doi: 10.1111/j.1749-6632.2001.tb03716.x. Ann N Y Acad Sci. 2001. PMID: 11594566 Review.
Cited by
-
Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma.Curr Med Chem. 2024;31(15):1983-2002. doi: 10.2174/0109298673237968231106095141. Curr Med Chem. 2024. PMID: 38031775 Review.
-
Mycosis fungoides and Sézary syndrome.Blood Res. 2023 Apr 30;58(S1):66-82. doi: 10.5045/br.2023.2023023. Blood Res. 2023. PMID: 37105561 Free PMC article. Review.
-
Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.Am J Hematol. 2023 Jan;98(1):193-209. doi: 10.1002/ajh.26760. Epub 2022 Oct 20. Am J Hematol. 2023. PMID: 36226409 Free PMC article.
-
Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.Am J Hematol. 2021 Oct 1;96(10):1313-1328. doi: 10.1002/ajh.26299. Epub 2021 Aug 2. Am J Hematol. 2021. PMID: 34297414 Free PMC article.
-
Transimmunization restores immune surveillance and prevents recurrence in a syngeneic mouse model of ovarian cancer.Oncoimmunology. 2020 May 13;9(1):1758869. doi: 10.1080/2162402X.2020.1758869. Oncoimmunology. 2020. PMID: 32566387 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources